LATEST ALERTS
Canadian cannabis producer Cronos Group saw overall reduced losses for the year, with results helped by sales growth in Canada and Israel but hindered by lower sales in the US
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
Japan has taken a step closer to legalising cannabinoid-based medicines and clarifying restrictions on hemp cultivation, though it is also set to strengthen measures against recreational cannabis use
Medical cannabis advocates in the Philippines have found an ally in a young senator, but there is still much to do
Amazon is expanding its UK CBD pilot, inviting firms that comply with UK novel food regulations onto its platform – clear evidence that support for CBD continues to become increasingly mainstream
Israeli cannabis firm InterCure is collaborating with US brand Cookies to launch Europe’s first flagship Cookies store in Vienna; meanwhile, Panaxia Labs exports to Germany from Malta
The US is in danger of being left behind the burgeoning global cannabis market because of a lack of political will to commit to any form of federal cannabis reform
CBD is already working from a higher base than many consumer products on the market. But that does not mean there is nothing else to be done
Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis
Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids
Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting from HIV
Thailand has removed the entire cannabis plant including flowers and seeds from the country’s list of Category 5 narcotics
Government support of Thailand’s hemp and CBD industry is paying off. Examples include US based Australis’ partnership with local GTH and MPX International’s agreement with Salus Thailand
CBD-Intel was on point in its 2021 predictions. Much like the preceding year, we believed 2021 would largely be defined more by what did not happen than what did
If 2020 was the year in the waiting-room then 2021 was perhaps the year of the unfulfilled hype. As predicted, there was little movement in many of the major issues controlling the CBD market
The acquisition of Mellow by US cannabis and CBD investment firm Thought Leaders will position the UK-based CBD marketplace to open in the US and bolster its position in Asia
A research team at the University Medical Center Groningen (UMCG) in the Netherlands recently launched a three-year study into whether medicinal cannabis oil can help to regress liver-cancer tumours
Thailand’s government is allowing farmers in the country’s Eastern Economic Corridor (EEC) to use 10,000 rai of undeveloped land to grow cannabis, hemp, and other medicinal herbs to help boost the economy and farmer’s standard of living
A series of changes in Thai law governing both medical cannabis and hemp has made the country one of the most cannabinoid-friendly countries in Asia
Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature
Swiss consumers are head-for-head the biggest purchasers of CBD products, according to CBD-Intel’s 2021 market size analysis. Meanwhile, we predict big growth in a number of other markets, and a shift in the most popular CBD category
Crisis-hit Armenia intends to legalise and regulate the production of hemp as a part of a package of economic measures to alleviate issues arising from the military conflict with Azerbaijan over the Nagorno-Karabakh region
Pakistan is set to embark on a path to the legal production of hemp and hemp-derived products following the approval last September of hemp farming and processing under government control
Tough Japanese laws on the import of CBD products and the cultivation of industrial hemp are becoming more challenging for the industry – and even stricter regulations may be on the way
CBD firms are making further advances into the health and wellness subcategory of the market with new product launches, distribution deals, and clinical studies underway
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
